CONTACTS 

SUBJECTS
Johnson, MD Meeting Reports No Evidence Distant Metastasis
CA 15-3 Blood Tests Show 36 Significant Drop into 30s
Chemo Therapy Treatments Scheduled to Begin 021002 1400
Chemotherapy Treatment Taxotere Today
White Blood Cell Count from Test Today OK 10.1 Nupogen Will Not be Ne
Blood Test on 020511 Showed that White Blood Cells Too Low for Chemot
White Blood Cell Count Too Low Again Treatment Performed 2nd Phase Ch

1709 -
1709 -    ..
1710 - Summary/Objective
1711 -
171101 - Follow up ref SDS 36 0000, ref SDS 35 0000.
171102 -
171103 - Phase II chemotherapy treatment today begins 4 cycles of Taxotere.
171104 - ref SDS 0 XA5N  White blood cell count from test a week ago is low,
171105 - but doctor approved treatment today based on test results showing
171106 - white blood cell count is rising.  The nurse had difficulty finding a
171107 - vein, eventually got help and treatment was performed, as scheduled.
171108 -
171109 -
171110 -
171111 -
171113 -  ..
1712 -
1713 -
1714 - Progress
1715 -
171501 - Recovery Progress CA 15-3 Cancer Marker Drops to Target Level
171502 - CA 15-3 Cancer Marker Drops to Target Level Progress Toward Recovery
171503 -
171504 - Follow up ref SDS 36 SQ5I, ref SDS 35 SQ5I.
171505 -
171506 - Millie had another blood test on 020930, following the meeting with
171507 - the primary care physician on 020924. ref SDS 36 N84F
171509 -  ..
171510 - Results of CA 15-3 were later reported to be 33.  This is very welcome
171511 - news because it shows a continuing trend down toward the target level
171512 - of 31 that indicates normal conditions.
171513 -
171514 -      [On 021023 CA 15-3 still 33. ref SDS 38 SQ5I
171515 -
171516 -
171518 -  ..
171519 - Taxotere Begin 4 Cycles Phase II Adjuvant Treatment Cancer Stage II
171520 -
171521 - Treatment today is the 1st of 4 cycles for phase II adjuvant treatment
171522 - with Taxotere following completion of radiation treatment on 020910,
171523 - including extra cycles, as reported during the meeting on 020924.
171524 - ref SDS 36 0J7H  This implements treatment planning scheduled by the
171525 - doctor on 020405, ref SDS 12 549R, based on the meeting held 020321.
171526 - ref SDS 10 FX7F
171528 -  ..
171529 - These 4 cycles of Taxotere for Phase II treatment will make 6 cycles
171530 - overall of Taxotere, because treatment was switched after only 2
171531 - cycles with Adriamycin and Cytoxan (AC) to Taxotere for the last 2
171532 - cycles of Phase I on 020610. ref SDS 28 MR5I
171533 -
171534 -        [On 021204 4th cycle Taxotere completes phase II adjuvant
171535 -        chemotherapy treatment. ref SDS 39 MO7O
171536 -
171537 -
171538 -
171540 -  ..
171541 - White Blood Cell Count Too Low, Treatment Given
171542 -
171543 - Kathy is the nurse today.
171544 -
171545 - The nurse reported results of the test on 020930 show that the white
171546 - blood cell count is again lower than the target range for chemotherapy
171547 - treatment, as occurred previously on 020513, when treatment was
171548 - delayed. ref SDS 24 0001  The nurse said today that other parts of the
171549 - test report show that white blood cells are increasing rapidly, so the
171550 - doctor has approved treatment today, similar to the condition on
171551 - 020701. ref SDS 32 EN50
171552 -
171556 -
171557 -                 Park Shadelands Medical Office
171559 -  ..
171560 - Follow Up Letter   Requested
171561 - Letter Code        LA1
171562 -
171563 -                           Regional Lab
171564 -
171565 -     Alkaline Phos          54.0  U/L       (     47.0  -    137   )
171566 -     Bili, Tot Adult         0.4  mg/dl     (      0.2  -      1.2 )
171567 -    CA 15-3                Test in Lab
171568 -     AST (SGOT)       H     31.0  U/L       (           -<    40   )
171570 -     ..
171571 -    CBC
171572 -     WBC x 10-.3      L      2.6  K/uL      (      3.5  -     12.5 )
171573 -     RBC x 10-.6             3.82 M/uL      (      3.60 -      5.70)
171574 -     Hemoglobin             11.9  g/dL      (     11.5  -     15.0 )
171575 -     Hematocrit             34.3  %         (     34    -     46.0 )
171576 -     MCV                    90    fL        (     80    -    100   )
171577 -     RDW              H     13.8  %         (     11.9  -     14.3 )
171578 -     Plt x 10-.3           209    K/uL      (    140    -    400   )
171580 -     ..
171581 -    ADIF
171582 -     Granulocytes     L     47    %         (     50    -     70   )
171583 -     Lymphocytes            37    %         (     20    -     50   )
171584 -     Monocyte               10    %         (      1    -     14   )
171585 -     Eosinophils      H      6    %         (      0    -      4   )
171586 -     Basophils               1    %         (      0    -      2   )
171587 -
171589 -  ..
171590 - Vein in Right Arm No Difficulty Finding
171591 -
171592 - Linda took less than 5 minutes to configure intravenous transfusion
171593 - for chemotherapy treatment today.
171594 -
171596 -  ..
171597 - Schedule for Completing 2nd Phase Chemotherapy Treatment
171598 -
171599 -
171600 -      021113   1400    WCR  ONC   Chemo             Taxotere
171601 -
171602 -      021204   1400    WCR  ONC   Chemo             Taxotere
171603 -
171604 -
171605 -
171606 -
171607 -
171608 -
171609 -
171610 -
171611 -
171612 -
1717 -